Table 2. Comparison of CXCR3 ligand actions in organ fibrosis.
| CXCL9 | CXCL10 | CXCL11 | |
|---|---|---|---|
| Profibrotic | Heart, Kidney, Skin | Heart, Liver | ? |
| Antifibrotic | Liver, Pancreas | Lung | Lung |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.